Description

2,3-Dihydroxy-7-sulfamoylbenzo(f)quinoxaline is a specialized heterocyclic organic compound featuring a quinoxaline core substituted with hydroxyl and sulfonamide functional groups. This unique molecular structure makes it a valuable intermediate for the synthesis of complex molecules, particularly in advanced research and development. It is primarily sought after by pharmaceutical and agrochemical R&D teams for its potential as a key building block in creating new active ingredients. The compound's properties are critical for applications requiring precise chemical modification and high-purity synthesis.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the research and synthesis of novel drug candidates, particularly those targeting specific enzymatic pathways.
• Agrochemical Research: Used in the development of new herbicides, fungicides, or pesticides, leveraging its heterocyclic structure for biological activity.
• Chemical Synthesis Building Block: Acts as a versatile scaffold for organic chemists to construct more complex molecules for material science or specialty chemicals.
• Biochemical Research: Potential use as a probe or inhibitor in biochemical assays due to its specific functional group interactions.
• Dye and Pigment Intermediate: May be utilized in the development of specialized dyes or pigments, given its conjugated quinoxaline system.
• Analytical Reference Standard: Employed as a high-purity standard in analytical laboratories for method development and quality control in related chemical processes.

Basic Information

Product Name	2,3-Dihydroxy-7-sulfamoylbenzo(f)quinoxaline
CAS No.	118876-57-6
Molecular Formula	C14H10N4O4S
Molecular Weight	330.32 g/mol
Synonyms	2,3-Dihydroxy-7-sulfamoylbenzo[f]quinoxaline; 7-Sulfamoyl-2,3-dihydroxybenzo[f]quinoxaline; Benzo[f]quinoxaline-2,3-diol-7-sulfonamide; 2,3-Dihydroxybenzo[f]quinoxaline-7-sulfonamide; BQSA; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our 2,3-Dihydroxy-7-sulfamoylbenzo(f)quinoxaline is manufactured under strict quality protocols to ensure batch-to-batch consistency and high purity. Each lot is subjected to comprehensive analytical testing, including HPLC for purity and identity confirmation. A Certificate of Analysis (COA) detailing all test results is provided with every shipment. We support compliance with cGMP and ISO 9001 standards for research and development applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept sealed in a dry environment to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.